Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.43%
SPX
+0.27%
IXIC
+0.37%
FTSE
+0.09%
N225
+0.87%
AXJO
+0.31%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
alny
Alnylam Pharmaceuticals
NASDAQ: ALNY
+27.38 (+6.02%)
482.41
USD
At close at Sep 09, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Alnylam Pharmaceuticals News

benzinga.com

$1000 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth This Much Today

7 days ago
cnbc.com

Goldman adds Walmart to September ‘conviction list.’ Here’s who else made the cut

Feature Image for interests on Consumer Cyclical, Consumer Defensive, ETF, Energy from cnbc.com
8 days ago
benzinga.com

Where Regeneron Pharmaceuticals Stands With Analysts

14 days ago
benzinga.com

A Closer Look at Alnylam Pharmaceuticals's Options Market Dynamics

19 days ago
benzinga.com

How Is The Market Feeling About Alnylam Pharmaceuticals?

28 days ago
benzinga.com

Where Alnylam Pharmaceuticals Stands With Analysts

about 1 month ago
benzinga.com

Beyond The Numbers: 15 Analysts Discuss Regeneron Pharmaceuticals Stock

about 1 month ago
benzinga.com

Alnylam Pharmaceuticals Q2 Earnings Crush Estimates, Stock Hits 52-Week High On Upbeat Forecast

Feature Image for interests on Biotech, Earnings, Healthcare, Large Cap from benzinga.com
about 1 month ago
benzinga.com

Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday

Feature Image for interests on Consumer Cyclical, Financial Services, Financials, Healthcare from benzinga.com
about 1 month ago
benzinga.com

Here's How Much $100 Invested In Alnylam Pharmaceuticals 15 Years Ago Would Be Worth Today

about 2 months ago
Join our newsletter to keep up to date with us!

Latest Cashu News

publisher logo
Cashu

Alnylam Pharmaceuticals: Leading Innovations in RNA Interference Therapeutics for Genetic Diseases

5 days ago
publisher logo
Cashu

Alnylam Pharmaceuticals: Leading Innovations in RNA Interference and Strong Stock Performance

6 days ago
publisher logo
Cashu

Alnylam Pharmaceuticals: Leading RNAi Therapeutics with Strong Market Performance and Innovation

8 days ago